Your browser doesn't support javascript.
loading
: 20 | 50 | 100
1 - 2 de 2
1.
Adv Ther ; 37(4): 1347-1359, 2020 04.
Article En | MEDLINE | ID: mdl-32141016

The purpose of this study is to review the current literature on the use of hyaluronic acid (HA) specifically applied to the treatment of osteoarthritis (OA) secondary to primary inflammatory rheumatic diseases. Osteoarthritis should be carefully considered because it has potentially devastating effects on health-related quality of life. Locally injected HA seems to be an effective treatment for OA but it is not clear how to place this treatment in the context of inflammatory rheumatic disorders. To retrieve relevant articles, we conducted the search through MEDLINE, EMBASE and Cochrane Databases performing the PICO strategy. We finally selected four randomized clinical trials and six observational studies and grouped them in accordance with its main objective within three focuses: the clinical effect of HA therapy in joints without any signs of inflammation, the clinical effects of HA therapy in joints with active synovitis, and the involvement and changes of synovial fluid in the treatment of secondary OA. Our qualitative analysis clearly showed that the current literature is marked by high levels of heterogeneity and therefore difficult to interpret. Therefore, our hypothesis that viscosupplementation should be considered as a treatment for chronic moderate symptomatic OA secondary to inflammatory rheumatic diseases, and not for flares with joint swelling, cannot be definitely supported. Well-designed studies are necessary to definitively clarify the range of application of intra-articular HA injections in the treatment of inflammatory rheumatic disorders.


Hyaluronic Acid/therapeutic use , Osteoarthritis/drug therapy , Osteoarthritis/etiology , Rheumatic Diseases/complications , Viscosupplements/therapeutic use , Humans , Hyaluronic Acid/administration & dosage , Inflammation/drug therapy , Injections, Intra-Articular , Quality of Life , Synovial Fluid/drug effects , Synovitis/drug therapy , Treatment Outcome , Viscosupplements/administration & dosage
2.
Expert Rev Neurother ; 16(12): 1413-1425, 2016 12.
Article En | MEDLINE | ID: mdl-27388277

INTRODUCTION: Chronification transforms episodic migraine into the pathologic chronic form. Biological characteristics of the migrainous brain progressively change, in predisposed subjects, under the repetition of external and internal stimuli. Modifications involve neurons, synapses, neurotransmitters, receptors, connectivity and pain control. f-MRI is a promising way to explore the still unclear biology of this progression. Areas covered: Data included were obtained from the most relevant and updated works available on PubMed about this topic. We summarized the pathophysiology of migraine chronification and of brain plasticity, and we described the different fMRI techniques and their main evidences about migraine transformation. Expert commentary: Functional-MRI has revealed many aspects regarding the peculiarity of the migrainous brain and its tendency toward chronicity but a series of questions are still open: What are the hallmarks of the predisposition to chronification? Which elements are the cause and which the consequence of this process?


Brain , Migraine Disorders , Disease Progression , Humans , Magnetic Resonance Imaging , Neuronal Plasticity , Neurotransmitter Agents
...